Nigel McCracken
Chief Operating Officer at VIRAX BIOLABS GROUP LIMITED
Nigel McCracken active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VIRAX BIOLABS GROUP LIMITED | Chief Operating Officer | 01/09/2023 | - |
Career history of Nigel McCracken
Former positions of Nigel McCracken
| Companies | Position | Start | End |
|---|---|---|---|
| BERGENBIO ASA | Chief Tech/Sci/R&D Officer | 01/01/2021 | 01/09/2023 |
Debiopharm International SA
 Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Director/Board Member | 01/09/2014 | 01/04/2019 |
| Corporate Officer/Principal | 01/09/2014 | 01/04/2019 | |
| NUCANA PLC | Chief Operating Officer | - | - |
Training of Nigel McCracken
| University of Strathclyde | Undergraduate Degree |
| King's College London | Graduate Degree |
Statistics
International
| United Kingdom | 5 |
| Switzerland | 2 |
| Norway | 2 |
Operational
| Chief Operating Officer | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| BERGENBIO ASA | Health Technology |
| NUCANA PLC | Health Technology |
| VIRAX BIOLABS GROUP LIMITED | Finance |
| Private companies | 1 |
|---|---|
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Nigel McCracken
- Experience